RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
-
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.
Authors: Lisa M Ebert, Yu Chih Liu, Craig S Clements, Neil C Robson, Heather M Jackson, Jessica L Markby, Nektaria Dimopoulos, Bee Shin Tan, Immanuel F Luescher, Ian D Davis,…
Cancer research 2009 Feb 1 -
NY-ESO-1: review of an immunogenic tumor antigen.
Authors: Sacha Gnjatic, Hiroyoshi Nishikawa, Achim A Jungbluth, Ali O Güre, Gerd Ritter, Elke Jäger, Alexander Knuth, Yao-Tseng Chen, Lloyd J Old
Advances in cancer research 2006
Thought leaders and organizations working on research involving NY-ESO 1.
- Ludwig Institute for Cancer Research
- Baylor College of Medicine
- Ludwig Institute for Cancer Research
- University of Arkansas for Medical Sciences
- National Cancer Institute
- Osaka University
- Peking University People's Hospital
-
NY-ESO Phase I Study for Prostate Cancer
conditions: Prostatic Neoplasms
interventions: NY-ESO-1 class I and class II peptide vaccine ; LAGE-1 class I and class II peptide vaccine
-
NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors
conditions: Tumors
interventions: NY-ESO-1 protein with CpG 7909 and Montanide
Community
